Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stinchcombe

Showing results (91-100 of 575) with videos related to

Pageof 58
Sort By:
Nature Reviews. Clinical Oncology|July 30, 2010
Targeted therapies: Biomarkers in NSCLC for selecting cetuximab therapyThomas E Stinchcombe, Mark A Socinski
Lancet (London, England)|September 22, 2009
Maintenance therapy in non-small-cell lung cancerThomas E Stinchcombe, Howard L West
The New Phytologist|July 4, 2009
Interspecific competition alters natural selection on shade avoidance phenotypes in Impatiens capensisBrechann V McGoey, John R Stinchcombe
Current Opinion in Oncology|May 18, 1999
Renal cell carcinomaP A Godley, T E Stinchcombe
The Journal of Cell Biology|October 6, 1999
Regulated secretion from hemopoietic cellsJ C Stinchcombe, G M Griffiths
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 11, 2005
Spatially heterogeneous dynamics in a model for granular compactionAlexandre Lefèvre, Ludovic Berthier, Robin Stinchcombe
Drugs|March 6, 2007
The role of induction therapy for resectable non-small cell lung cancerThomas E Stinchcombe, Mark A Socinski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
KRAS mutation: should we test for it, and does it matter?Patrick J Roberts, Thomas E Stinchcombe
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 16, 2013
Nonuniversal disordered Glauber dynamicsMarcelo D Grynberg, Robin B Stinchcombe
The Oncologist|April 26, 2012
Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancerThomas E Stinchcombe, Jeffrey A Bogart
Pageof 58

Showing results (91-100 of 575) with videos related to

Sort By:
Pageof 58
Nature Reviews. Clinical Oncology|July 30, 2010
Targeted therapies: Biomarkers in NSCLC for selecting cetuximab therapyThomas E Stinchcombe, Mark A Socinski
Lancet (London, England)|September 22, 2009
Maintenance therapy in non-small-cell lung cancerThomas E Stinchcombe, Howard L West
The New Phytologist|July 4, 2009
Interspecific competition alters natural selection on shade avoidance phenotypes in Impatiens capensisBrechann V McGoey, John R Stinchcombe
Current Opinion in Oncology|May 18, 1999
Renal cell carcinomaP A Godley, T E Stinchcombe
The Journal of Cell Biology|October 6, 1999
Regulated secretion from hemopoietic cellsJ C Stinchcombe, G M Griffiths
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 11, 2005
Spatially heterogeneous dynamics in a model for granular compactionAlexandre Lefèvre, Ludovic Berthier, Robin Stinchcombe
Drugs|March 6, 2007
The role of induction therapy for resectable non-small cell lung cancerThomas E Stinchcombe, Mark A Socinski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
KRAS mutation: should we test for it, and does it matter?Patrick J Roberts, Thomas E Stinchcombe
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 16, 2013
Nonuniversal disordered Glauber dynamicsMarcelo D Grynberg, Robin B Stinchcombe
The Oncologist|April 26, 2012
Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancerThomas E Stinchcombe, Jeffrey A Bogart
Pageof 58